Views & News
In light of the recent universal bullishness, is it time for some caution?
Clive and James discuss the macro and the micro, from global economics to new portfolio additions and whether the ‘vaccine value rally’ can conti...
In light of the recent universal bullishness, is it time for some caution?
Clive and James discuss the macro and the micro, from global economics to new portfolio additions and whether the ‘vaccine value rally’ can conti...
With Covid-19 case numbers rising rapidly, James Syme reviews the portfolio's Indian exposure.
In their latest update, Rachel Reutter and Michael Ulrich focus on four topics that have been dominating their thoughts and actions over the last quarter.
Alex and Tom provide an update on a strong quarter for the portfolio as operating performance and share price momentum continued to build.
The current debate on incipient inflation is the elephant in the room. Samir Mehta provides his thoughts.
10 things we are thinking about for the rate regime that may lie ahead.
James and Clive on why the shift in stock market leadership towards 'value' has much further to run.
A look at the investment landscape in Europe and the key areas where we are finding opportunities.
A top-down look at Brazil from the JOHCM Global Emerging Markets Opportunities team.
For a better experience, we recommend viewing this website in landscape orientation.
